Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
1993-5-5
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Feb
|
pubmed:issn |
0014-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
192
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
147
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:8465051-Carcinoid Tumor,
pubmed-meshheading:8465051-Digestive System Neoplasms,
pubmed-meshheading:8465051-Female,
pubmed-meshheading:8465051-Humans,
pubmed-meshheading:8465051-Male,
pubmed-meshheading:8465051-Middle Aged,
pubmed-meshheading:8465051-Octreotide,
pubmed-meshheading:8465051-Remission Induction
|
pubmed:year |
1993
|
pubmed:articleTitle |
[The Sandostatin treatment of digestive carcinoid tumors].
|
pubmed:publicationType |
Letter
|